Eureka In the News

Janaury 26, 2018 – BioCentury

BioCentury logo| Eureka Raises $60M Series D


January 24, 2018 – Fortune

Fortune logo| Eureka Therapeutics Inc. raised $60 million in Series D funding


January 22, 2018 – FierceBiotech

Fierce Biotech logo| Eureka nets $60M to take T-cell therapy into the clinic


January 22, 2018 – BioSpace

BioSpace logo| Bay Area’s Eureka Therapeutics Banks $60M


January 22, 2018 – Reuters

Reuters logo| BRIEF-Eureka Therapeutics Closes $60 Mln In Series D Financing


December 6, 2017 – BioCentury

BioCentury logo| Juno Licenses Gamma Secretase Inhibitor Related IP


December 1, 2017 – Lymphoma News Today

Lymphoma News Today logo| Eureka Technologies Receives FDA’s OK to Move T-cell Therapy into Clinical Trials


July 20, 2017 – BioCentury

BioCentury logo| Eureka a moment for TCR Mimics


June 12, 2017 – Liver Disease News

Liver Disease News logo| Eureka, City of Hope to Conduct Phase 1 Trial of Investigational CAR T-cell Therapy for Liver Cancer


September 20, 2016 – Seeking Alpha

Seeking Alpha logo| Deal Flurry Shines Spotlight On Novel Multiple Myeloma Target


August 6, 2016 – BioCentury

BioCentury logo| Eureka Therapeutics, Memorial Sloan Kettering, Juno Therapeutics Deal


August 5, 2016 – Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology News logo| Juno Licenses BCMA from MSK, Eureka Therapeutics


May 22, 2015 – Xconomy

Xconomy logo| West Coast Biotech Roundup: Illumina, Veracyte, Otonomy, Kite & More


November 21, 2014 – The E’Ville Eye

The E'ville Eye logo| Plum Organics, Eureka Therapeutics & Interior Designer Lauren Geremia


September 29, 2014 – BioCentury

| Eureka Raises $21M In C Round


September 24, 2014 – San Francisco Business Times

San Francisco Business Times logo| Emeryville Cancer Drug Developer Lands $21M From Chinese, Other Investors


September 24, 2014 – FierceBiotech

Fierce Biotech logo| Novartis-Partnered Eureka Rounds Up $21M Round For Immuno-Oncology Drug Research


September 23, 2014 – WSJ Venture Capital 

WSJ Venture Capital logo| Eureka Therapeutics Raises $21M Series C Financing


September 23, 2014 – MedCity News

Med City News logo| Startup Gets $21M For Monoclonal Antibody That Reaches Inside The Cancer Cell


February 3, 2014 – BioCentury

BioCentury logo| Eureka Therapeutics, Novartis, Memorial Sloan Kettering Deal